Skip to content

Resistant Starch Type-3, Glucose Metabolism and Appetite

Impact of Resistant Starch Type-3 on Glucose Metabolism and Appetite in Healthy Adult Males

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05108142
Enrollment
8
Registered
2021-11-04
Start date
2019-11-01
Completion date
2020-03-15
Last updated
2021-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Resistant Starch

Brief summary

Resistant starch (RS) is considered to have many of the same health benefits as dietary fiber. The aim of this study was to examine the effects of RS3 on postprandial glycemic and insulinemic responses and appetite. Healthy males (aged 18-35 years) participated in this study. Subjects were provided meals in the laboratory after overnight fasting on two separate occasions, at least 1 week apart. On each laboratory visit, subjects were given either a control meal (COM) or an RS3 meal (RSM). Both meals during the two visits consisted of vegetarian pasta and were matched for energy intake, composition, ingredients, and amount, but were prepared in different ways. The COM was hot, freshly cooked pasta, while the RSM was re-heated pasta that had been cooked the previous day and chilled overnight. Blood samples and subjective appetite ratings were collected at fasting and for a period of 3 h after meal consumption (i.e., 15-min intervals for glucose and 30-min intervals for insulin, ghrelin, and subjective appetite).

Interventions

OTHERDietary intervention

fresh, hot pasta and re-heated pasta

Sponsors

King Saud University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy males * Aged between 18 and 40 years * Normal weight (BMI 18.5-24.9 kg/m2) * No history of serious disease or currently taking any medications * Not dieting or seeking to lose weight.

Exclusion criteria

* Smokers * Allergy to gluten-containing products, lactose intolerance, or dairy allergy * Particular dislike to any of the foods provided during the study.

Design outcomes

Primary

MeasureTime frameDescription
Changes in fasting and postprandial blood glucose concentrations (n=8)3 hoursFasting and postprandial blood glucose assessed with the use of a portable monitor (Accu-Chek) during laboratory visits (before and 3 hours following the meal consumption in the two visits).

Secondary

MeasureTime frameDescription
Changes in of fasting and postprandial serum insulin concentrations (n=8)3 hoursFasting and postprandial serum insulin assessed using a commercial kit during laboratory visits (before and 3 hours following the meal consumption in the two visits)
Changes in subjective appetite ratings (Visual Analogue Scale) (n=8)3 hoursSubjective appetite ratings were assessed during laboratory visits (before and 3 hours following the meal consumption in the two visits) with the use of paper-based visual analog scales with words anchored at each end of a 100-mm horizontal line that expressed the most-positive rating and the most-negative rating for a question. The questions were in the form of How (rating) do you feel? (with ratings of hungry, satisfied, and full), How much of a desire to eat? and How much do you think you can eat?
Changes in fasting and postprandial plasma ghrelin concentrations (n=8)3 hoursFasting and postprandial ghrelin assessed using a commercial kit during laboratory visits (before and 3 hours following the meal consumption in the two visits)

Countries

Saudi Arabia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026